| 5.96 -1.06 (-15.1%) | 06-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.14 | 1-year : | 13.01 |
| Resists | First : | 9.53 | Second : | 11.14 |
| Pivot price | 4.59  |
|||
| Supports | First : | 4.95 | Second : | 2.11 |
| MAs | MA(5) : | 6.86 |
MA(20) : | 4.77 |
| MA(100) : | 11.39 |
MA(250) : | 19.71 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 71.5 |
D(3) : | 70.3 |
| RSI | RSI(14): 50.7 |
|||
| 52-week | High : | 42 | Low : | 2.11 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ICCM ] has closed below upper band by 33.8%. Bollinger Bands are 57.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.56 - 6.59 | 6.59 - 6.62 |
| Low: | 5.52 - 5.56 | 5.56 - 5.6 |
| Close: | 5.9 - 5.96 | 5.96 - 6.01 |
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Sat, 27 Jun 2026
IceCure Medical Ltd. Actuals & Estimates (BOATS:ICCM) - TradingView
Fri, 26 Jun 2026
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC Filing - Form 6-K - Stock Titan
Fri, 26 Jun 2026
What's Going On With IceCure Medical Stock On Friday? - Benzinga
Fri, 26 Jun 2026
IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
Thu, 25 Jun 2026
Icecure Medical(ICCM) Stock Options Chain | Quotes & News - Moomoo
Thu, 25 Jun 2026
ICCM: Selling Stockholders Plan to Offer 5.5 Million Shares - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 3 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 39.9 (%) |
| Held by Institutions | 3.8 (%) |
| Shares Short | 24 (K) |
| Shares Short P.Month | 37 (K) |
| EPS | -7.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.14 |
| Profit Margin | 0 % |
| Operating Margin | -466.2 % |
| Return on Assets (ttm) | -80.4 % |
| Return on Equity (ttm) | -217.3 % |
| Qtrly Rev. Growth | 25.7 % |
| Gross Profit (p.s.) | 0.46 |
| Sales Per Share | 1.26 |
| EBITDA (p.s.) | -5.49 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -15 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -0.83 |
| PEG Ratio | 0 |
| Price to Book value | 1.89 |
| Price to Sales | 4.7 |
| Price to Cash Flow | -1.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|